Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 HKD | -1.11% |
|
+2.69% | -23.05% |
25/06 | Sino Biopharmaceutical Gets NMPA's Nod for Marketing Diabetes Drug | MT |
25/06 | Sino Biopharmaceutical Limited Receives Approval for Marketing of Liraglutide Injection | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.05% | 6.27B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Sino Biopharmaceutical Gets NMPA's Nod for Marketing Diabetes Drug